Advantage Alpha Capital Partners’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-69,207
Closed -$257K 168
2024
Q3
$257K Buy
+69,207
New +$257K 0.06% 164